METASTATIC ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA

Clinical trials for METASTATIC ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new METASTATIC ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for METASTATIC ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo trial aims to control advanced uterine cancer

Disease control Ongoing

This study is testing whether adding a new drug called ipatasertib to a standard hormone therapy (megestrol acetate) is more effective at controlling advanced endometrial cancer than the hormone therapy alone. It involves about 96 women whose cancer has returned or spread. The ma…

Matched conditions: METASTATIC ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 18, 2026 14:41 UTC

METASTATIC ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA

Get alerted when new METASTATIC ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA trials appear

New drug combo trial aims to control advanced uterine cancer